Lantern Pharma Inc. (LTRN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 33.02M |
| Enterprise Value | 107.14M |
| P/E Ratio | -2.68 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 12.67 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.2 |
| Return On Equity | -0.01 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -17.1M |
| Net Income | -17.12M |
| Diluted EPS | -1.57 |
| Total Cash | 6.32M |
| Total Cash/Share | 0.56 |
| Total Debt | 59,076 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.87 |
| Book Value Per Share | 0.31 |
| 52-Week Change | 26.38 |
| 52-Week High | 5.74 |
| 52-Week Low | 1.11 |
| Moving Average 50 Days | 2.92 |
| Moving Average 200 Days | 3.23 |
| Average Volume | 708,435 |
| Shares Outstanding | 12.76M |
| % Held by Institutions | 19.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |